There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Allowing Greater Access to Safe and Effective Contraception Act

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to allow women greater access to safe and effective contraception.

Actions Overview (1)

Date Actions Overview
05/21/2015Introduced in Senate

All Actions (1)

Date All Actions
05/21/2015Read twice and referred to the Committee on Finance.
Action By: Senate

Cosponsors (8)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Gardner, Cory [R-CO]* 05/21/2015
Sen. Ernst, Joni [R-IA]* 05/21/2015
Sen. Burr, Richard [R-NC]* 05/21/2015
Sen. Johnson, Ron [R-WI]* 05/21/2015
Sen. Tillis, Thom [R-NC]* 05/21/2015
Sen. Heller, Dean [R-NV]* 05/21/2015
Sen. Toomey, Pat [R-PA] 06/16/2015
Sen. Murkowski, Lisa [R-AK] 06/25/2015

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Finance05/21/2015 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Subjects (7)

Latest Summary (1)

There is one summary for S.1438. View summaries

Shown Here:
Introduced in Senate (05/21/2015)

Allowing Greater Access to Safe and Effective Contraception Act

This bill requires the Food and Drug Administration (FDA) to prioritize review of supplemental drug applications (applications to modify the approved use of a drug) for contraceptive drugs intended for routine use that would be available to individuals aged 18 and older without a prescription. The FDA must waive user fees for such supplemental drug applications. Any drug that is eligible for this priority review must be a prescription drug for individuals under age 18.

This bill repeals provisions of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 to allow health savings accounts and health flexible spending accounts (HFSAs) to be used to pay for medicine without a prescription and to remove the limit on salary reduction contributions to a HFSA under a cafeteria plan, effective as if the provisions had never been enacted.